Mass General Brigham Cancer Institute — Danvers, Massachusetts

Mass General Brigham Cancer Institute is a clinical research site located in Danvers, Massachusetts, United States 01923.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mass General Brigham Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Immune Thrombocytopenia.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Danvers

Browse all research sites in Massachusetts · View every site in Danvers

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Brigham Cancer Institute?

Mass General Brigham Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Brigham Cancer Institute conducted?

Mass General Brigham Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Immune Thrombocytopenia.

Is Mass General Brigham Cancer Institute accredited by Crixeo Clinical Trials?

Mass General Brigham Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Brigham Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.